U.S. Food and Drug Administration (FDA)

The U.S. Food and Drug Administration (FDA) is a pivotal federal agency headquartered in Silver Spring, Maryland. It operates under the Department of Health and Human Services and is dedicated to safeguarding public health through the regulation of food safety, pharmaceuticals, medical devices, and other products impacting health and wellness.

Financial Indicators

Unlike traditional companies, the FDA does not generate revenue. Instead, it operates with a budget allocated by the federal government. For the fiscal year 2023, the FDA's budget is approximately $6.4 billion. This funding is essential for supporting the agency's comprehensive regulatory activities and innovative initiatives.

Significant Events

A significant milestone for the FDA was the completion of its first AI-assisted scientific review pilot program. This initiative is part of a broader strategy to incorporate technological advancements, aiming to streamline scientific reviews, reduce the time needed to bring innovations to market, and maintain safety and efficacy standards.

The FDA has been vigilant in ensuring the safety of infant nutrition, recommending recalls due to epidemiological links between certain infant formulas and illnesses. This prompted an investigation into contamination sources and increased scrutiny on suppliers and manufacturers involved in powdered infant nutrition. Additionally, the FDA issued a warning regarding the sale of ByHeart’s Whole Pasture-Raised Goat Milk Infant Formula due to potential contamination with Clostridium botulinum.

Future Plans

Following the success of the AI pilot, the FDA plans to expand the use of AI technology across all its centers by June 2025. This expansion aims to improve consistency, reduce human error, and enhance overall efficiency in regulatory affairs.

The FDA has also proposed a Healthy Labeling Rule to establish front-of-package rating labels for saturated fat, sodium, and added sugar, with public comments invited until July 15, 2025. A 60-day aging requirement for raw milk cheeses has been set, although this regulation is currently under scrutiny due to recent research findings.

Additionally, the FDA announced new restrictions on synthetic dyes, promoting a transition to natural alternatives. It continues to express concerns over unpasteurized milk due to risks like bacterial contamination and bird flu detected in California's raw milk samples. The FDA has accepted the GRAS notice from Formo and Those Vegan Cowboys, marking the final phase before issuing a no-questions letter, and is involved in ongoing investigations and the recall process of potentially contaminated cheese products.

There has been a petition from Thai dairy farmers urging the FDA to implement mandatory labeling reforms on dairy products to enable consumers to make informed choices.

Modified: 2026/07/27